No trading action warranted. This is a routine clerical correction with zero economic impact. Monitor future filings for actual equity grants under the plan.
Price Chart
Executive Summary
Psyence Biomedical filed an amended equity incentive plan (6-K) to correct a typographical error in Section 4(b) of its 2023 Equity Incentive Plan. The filing is a routine administrative amendment with no material financial impact.
Key Facts
- On May 4, 2026, the Board approved an amendment to correct a typographical error in Section 4(b) of the existing 2023 Equity Incentive Plan.
- The Plan Share Limit remains unchanged at 13,635 post-share consolidation shares (8,150,126 pre-consolidation).
- No new share grants, dilution, or changes to outstanding awards are described in this filing.
Financial Impact
No financial impact — the amendment is purely administrative (correcting a typo) with no change to share count, dilution, or economics.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-065824 |
| Document: ea0293772-6k_psyence.htm | 0001213900-26-065824 |
| Document: 0001213900-26-065824-index-headers.html | 0001213900-26-065824 |
| Document: 0001213900-26-065824-index.html | 0001213900-26-065824 |
| Document: 0001213900-26-065824.txt | 0001213900-26-065824 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 5, 2026 20w ago | 6-K | $0.0500 $0.0236 | ▼ −52.80% | ▼ −55.85% | — |
Apr 23, 2026 26w ago | 6-K | $0.0200 $0.0301 | ▲ +50.50% | ▲ +45.42% | — |
Apr 20, 2026 27w ago | 6-K | $0.0200 $0.0200 | · 0.00% | ▲ +6.78% | — |
Apr 17, 2026 27w ago | 6-K | $0.0200 $0.0200 | · 0.00% | ▼ −6.78% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers